145 related articles for article (PubMed ID: 15356160)
1. Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus.
Mackay GA; Liu Z; Singh DK; Smith MS; Mukherjee S; Sheffer D; Jia F; Adany I; Sun KH; Dhillon S; Zhuge W; Narayan O
J Immunol; 2004 Sep; 173(6):4100-7. PubMed ID: 15356160
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic simian/human immunodeficiency virus SHIV(KU) inoculated into immunized macaques caused infection, but virus burdens progressively declined with time.
Silverstein PS; Mackay GA; Mukherjee S; Li Z; Piatak M; Lifson JD; Narayan O; Kumar A
J Virol; 2000 Nov; 74(22):10489-97. PubMed ID: 11044093
[TBL] [Abstract][Full Text] [Related]
3. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
4. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
5. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
[TBL] [Abstract][Full Text] [Related]
6. Live-attenuated lentivirus immunization modulates innate immunity and inflammation while protecting rhesus macaques from vaginal simian immunodeficiency virus challenge.
Genescà M; Ma ZM; Wang Y; Assaf B; Qureshi H; Fritts L; Huang Y; McChesney MB; Miller CJ
J Virol; 2012 Sep; 86(17):9188-200. PubMed ID: 22696662
[TBL] [Abstract][Full Text] [Related]
7. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
Stephens EB; Joag SV; Atkinson B; Sahni M; Li Z; Foresman L; Adany I; Narayan O
Virology; 1997 Aug; 234(2):328-39. PubMed ID: 9268165
[TBL] [Abstract][Full Text] [Related]
8. Antiviral CD8+ T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6.
Genescà M; McChesney MB; Miller CJ
J Intern Med; 2009 Jan; 265(1):67-77. PubMed ID: 19093961
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization of macaques with attenuated vaccine virus induces protection against vaginally transmitted AIDS.
Joag SV; Liu ZQ; Stephens EB; Smith MS; Kumar A; Li Z; Wang C; Sheffer D; Jia F; Foresman L; Adany I; Lifson J; McClure HM; Narayan O
J Virol; 1998 Nov; 72(11):9069-78. PubMed ID: 9765452
[TBL] [Abstract][Full Text] [Related]
10. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.
Yankee TM; Sheffer D; Liu Z; Dhillon S; Jia F; Chebloune Y; Stephens EB; Narayan O
Virology; 2009 Jan; 383(1):103-11. PubMed ID: 18986665
[TBL] [Abstract][Full Text] [Related]
12. Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
Vogel TU; Reynolds MR; Fuller DH; Vielhuber K; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Marthas ML; Erfle V; Wolinsky SM; Wang C; Allison DB; Rud EW; Wilson N; Montefiori D; Altman JD; Watkins DI
J Virol; 2003 Dec; 77(24):13348-60. PubMed ID: 14645590
[TBL] [Abstract][Full Text] [Related]
13. Protection of macaques against AIDS with a live attenuated SHIV vaccine is of finite duration.
Kumar A; Liu Z; Sheffer D; Smith M; Singh DK; Buch S; Narayan O
Virology; 2008 Feb; 371(2):238-45. PubMed ID: 17988702
[TBL] [Abstract][Full Text] [Related]
14. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.
De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602
[TBL] [Abstract][Full Text] [Related]
16. With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
Genescà M; Skinner PJ; Hong JJ; Li J; Lu D; McChesney MB; Miller CJ
J Virol; 2008 Nov; 82(22):11181-96. PubMed ID: 18787003
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
[TBL] [Abstract][Full Text] [Related]
18. Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.
Lewis MG; Yalley-Ogunro J; Greenhouse JJ; Brennan TP; Jiang JB; VanCott TC; Lu Y; Eddy GA; Birx DL
J Virol; 1999 Feb; 73(2):1262-70. PubMed ID: 9882330
[TBL] [Abstract][Full Text] [Related]
19. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.
Abel K; Rourke T; Lu D; Bost K; McChesney MB; Miller CJ
J Infect Dis; 2004 Nov; 190(9):1697-705. PubMed ID: 15478078
[TBL] [Abstract][Full Text] [Related]
20. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
